As of November 2024, Protagenic Therapeutics has a market cap of $2.79M. This makes Protagenic Therapeutics the world's 35551th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.90M | -11.11% |
2023 | $4.39M | -38.13% |
2022 | $7.10M | -71.12% |
2021 | $24.57M | 31.90% |
2020 | $18.63M | -25.53% |
2019 | $25.01M | -29.50% |
2018 | $35.48M | -9.09% |
2017 | $39.03M | -71.55% |
2016 | $137.17M | 150.00% |
2015 | $54.87M | -83.33% |
2014 | $329.21M | -40.00% |
2013 | $548.68M | -53.49% |
2012 | $1.18B | -51.14% |
2011 | $2.41B | -99.67% |
2010 | $727.00B | 1.92% |
2009 | $713.28B | -43.48% |
2008 | $1.26T | -91.79% |
2007 | $15.36T | -77.78% |
2006 | $69.13T | 425.00% |
2005 | $13.17T | -70.37% |
2004 | $44.44T | -32.50% |
2003 | $65.84T | -88.57% |
2002 | $576.11T | -27.69% |
2001 | $796.68T | 21.00% |
2000 | $658.41T | -11.11% |
1999 | $740.72T | -66.67% |
1998 | $2222.15T | 35.00% |
1997 | $1646.04T | -13.04% |
1996 | $1892.94T | - |